L'entretien de David Solomon (Pharnext)

from Le Journal des Biotechs · host BOURSORAMA

L'entretien est consacré à David Solomon. Six mois après son arrivée à la direction générale de Pharnext, il explique la stratégie de la société avec une priorité accordée à la nouvelle étude de Phase III de PXT3003. Il revient également sur le potentiel de la plateforme de pléothérapie.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Episode metadata supplied by the publisher feed · Published Oct 15, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

L'entretien de David Solomon (Pharnext)

0:00 13:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

David Burnell: Sorab and Rustum - The Son He Never Knew

Apr 10, 2026 ·8m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Le Journal des Biotechs?

This episode is 13 minutes long.

When was this Le Journal des Biotechs episode published?

This episode was published on October 15, 2020.

Can I download this Le Journal des Biotechs episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!